Nurslix
— 藥理與非經腸給藥 · MCQ —

一位糖尿病酮酸血症(DKA)病人正接受短效胰島素(regular insulin)持續靜脈輸注與 0.9% 生理食鹽水。血糖由 420 mg/dL 降至 240 mg/dL,但血清重碳酸鹽為 14 mEq/L、靜脈血 pH 7.24,血中酮體仍升高。護理師應預期哪一項處置?

A client with diabetic ketoacidosis (DKA) is receiving a continuous intravenous infusion of regular insulin and 0.9% sodium chloride. The blood glucose has decreased from 420 mg/dL to 240 mg/dL, but the serum bicarbonate is 14 mEq/L, the venous pH is 7.24, and blood ketones remain elevated. Which intervention should the nurse anticipate?

  • AStop the insulin infusion now that the blood glucose is below 250 mg/dL血糖已低於 250 mg/dL,停止胰島素輸注
  • BAdd dextrose to the intravenous fluids and continue the insulin infusion at a reduced rate在靜脈輸液中加入葡萄糖,並以調降後的速率繼續胰島素輸注正確答案
  • CIncrease the insulin infusion rate to bring the blood glucose to normal more quickly提高胰島素輸注速率,讓血糖更快降到正常
  • DHold the intravenous fluids until the blood glucose is below 200 mg/dL暫停靜脈輸液,直到血糖低於 200 mg/dL
— Answer · 正確答案 —
  • B在靜脈輸液中加入葡萄糖,並以調降後的速率繼續胰島素輸注
— Why · 為什麼是這個答案 —

正確答案是 B。DKA 治療的目標不只是降血糖,而是關閉酮體生成、矯正酸血症與脫水。依 2024 年 ADA/EASD/JBDS/AACE/DTS 高血糖危象共識,當血糖降到 250 mg/dL 以下但酮酸血症尚未解除(酮體仍高、重碳酸鹽偏低、pH 未回到 7.3)時,應在靜脈輸液中加入 5–10% 葡萄糖,並把胰島素輸注速率調降(約 0.05 單位/公斤/小時),維持血糖約 200 mg/dL,讓胰島素持續抑制酮體生成直到酮酸血症解除。A:酮酸血症未解除前停用胰島素會使酮體再生、DKA 反彈。C:血糖已降到目標區間,再加速會造成低血糖與滲透壓驟變,增加腦水腫風險。D:DKA 病人仍處於脫水狀態,靜脈輸液必須持續以矯正體液不足與灌流,不可暫停。護理另需監測血鉀,血清鉀低於 5.0 mEq/L 時依醫囑補鉀,並每小時追蹤血糖與生命徵象。來源:Umpierrez et al., Hyperglycemic Crises in Adults With Diabetes: A Consensus Report(Diabetes Care, 2024);ADA Hyperglycemic Crises Consensus(Kitabchi et al., 2009)。

— Options · 其他選項為什麼不對 —
  • A血糖已低於 250 mg/dL,停止胰島素輸注

    錯誤。酮酸血症尚未解除(酮體仍高、重碳酸鹽 14 mEq/L、pH 7.24),此時停用胰島素會使酮體再生、DKA 反彈。

  • B · 正確答案在靜脈輸液中加入葡萄糖,並以調降後的速率繼續胰島素輸注

    正確。血糖低於 250 mg/dL 而酮酸血症未解除時,應加入 5–10% 葡萄糖並以調降的速率繼續胰島素輸注,維持血糖約 200 mg/dL 直到酸血症矯正。

  • C提高胰島素輸注速率,讓血糖更快降到正常

    錯誤。血糖已在目標區間,提高輸注速率會造成低血糖與滲透壓驟變,增加腦水腫風險。

  • D暫停靜脈輸液,直到血糖低於 200 mg/dL

    錯誤。DKA 病人仍嚴重脫水,靜脈輸液必須持續矯正體液不足與灌流,不可為了等血糖數值而暫停。

✦ 台美臨床差異

美國多數醫院有護理師主導的胰島素輸注流程(nurse-driven insulin infusion protocol),護理師可依流程調整速率並加上葡萄糖輸液;台灣多由醫師逐次開立調整醫囑。但兩地 DKA 處置準則一致:血糖低於 250 mg/dL 就加葡萄糖,酮酸血症解除才停止輸注。

English explanation

Option B is correct. The goal of DKA treatment is not simply to lower the glucose but to shut off ketone production and correct the acidosis and dehydration. According to the 2024 ADA/EASD/JBDS/AACE/DTS consensus on hyperglycemic crises, once the blood glucose falls below 250 mg/dL while ketoacidosis persists (ketones still elevated, bicarbonate low, pH not yet 7.3), dextrose 5% to 10% is added to the intravenous fluids and the insulin infusion is reduced to about 0.05 units/kg/hr, maintaining the glucose at about 200 mg/dL so insulin can keep suppressing ketogenesis until the acidosis resolves. Option A is incorrect because stopping insulin before ketoacidosis resolves allows ketone production to resume and DKA to rebound. Option C is incorrect because the glucose is already in the target range; a faster decline risks hypoglycemia and abrupt osmotic shifts that increase the risk of cerebral edema. Option D is incorrect because the client is still volume depleted and intravenous fluids must continue to restore perfusion; they are never held to wait for a glucose value. The nurse also monitors potassium, replacing it as prescribed when the serum level falls below 5.0 mEq/L, and checks glucose and vital signs hourly. Source: Umpierrez et al., Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (Diabetes Care, 2024); ADA Hyperglycemic Crises Consensus (Kitabchi et al., 2009).

最近修訂:2026-10-06

— Related · 同分類的其他題目 —

More from Pharmacological & Parenteral

瀏覽全部 63 題 藥理與非經腸給藥 →
— Jump to another chapter —